CompaniesAlgenics

Algenics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

112

By Phase

PHASE1/PHASE2: 2PHASE1: 1

By Status

COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT05052398
Hover over trial bars to see details

Recent Trials

NCT05052398Lead Sponsor
Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy
PHASE1/PHASE2Recruiting
52 participants
Started: Jan 14, 2021 · Completed: Jul 14, 2025
NCT04799041Lead Sponsor
Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study
PHASE1/PHASE2Completed
30 participants
Started: Oct 11, 2019 · Completed: Mar 19, 2020
NCT03655522Lead Sponsor
NAVX-010-Phase I Tolerability and Pharmacokinetic Study in Healthy Male Subjects
PHASE1Completed
30 participants
Started: May 14, 2015 · Completed: Sep 2, 2015